J Appl Biomed 10:187-193, 2012 | DOI: 10.2478/v10136-012-0010-2

Acute poisoning with sarin causes alteration in oxidative homeostasis and biochemical markers in Wistar rats

Miroslav Pohanka1,*, Jaroslav Románek1, Jiří Pikula2
1 Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic
2 Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic

Sarin is a potent inhibitor of acetylcholinesterase (AChE). It is known as an agent of chemical warfare and is one of a number of nerve agents misused for chemical terrorism, e.g. on the Tokyo subway attacks. Though effect of sarin on the cholinergic system is well-known, long-term adverse effects and the role of oxidative stress in sarin toxicity remain unknown. The experiment reported here was carried out on laboratory Wistar rats intramuscularly exposed to 0.5-50% of sarin LD50 for one hour. A complex biochemical examination of plasma samples and an assessment of oxidative stress in the liver, kidney, spleen, cerebellum and frontal lobe were performed after euthanasia of the animals. By means of these biochemical markers, we were able to observe the induction of hyperglycaemia in a dose-dependent manner. Other biochemical markers such as transaminases were influenced in a non-standard manner as sarin probably acted as an inhibitor of these markers. Oxidative stress markers and an assessment of AChE activity showed an unequal impact of sarin on different tissues. Significant inhibition of AChE was found in the cerebellum and frontal lobe. Besides this, alterations in reduced glutathione, ferric reducing antioxidant power (FRAP) and thiobarbituric acid reactive substances (TBARS) were proven. In particular, an accumulation occurred of reduced glutathione in the frontal lobe, whereas depletion of FRAP was found in the kidney and spleen, and a strong increase in TBARS occurred in the spleen in a dose-dependent manner. We infer that sarin extensively influences oxidative homeostasis. Surprisingly, the central nervous system seems to be more resistant than the other organs.

Keywords: sarin; nerve agents; chemical warfare; acetylcholinesterase; oxidative stress; antioxidant; biochemistry

Received: December 8, 2011; Revised: January 30, 2012; Published: July 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pohanka M, Románek J, Pikula J. Acute poisoning with sarin causes alteration in oxidative homeostasis and biochemical markers in Wistar rats. J Appl Biomed. 2012;10(4):187-193. doi: 10.2478/v10136-012-0010-2.
Download citation

References

  1. Abu-Qare AW, Abou-Donia MB. Combined exposure to sarin and pyridostigmine bromide increase levels of rat urinary 3-nitrotyrosine and 8-hydroxy-2'-deoxyguanosine, biomarkers of oxidative stress. Toxicol Lett. 123: 51-58, 2001. Go to original source... Go to PubMed...
  2. Abu-Qare AW, Abou-Donia MB. Sarin: health effects, metabolism, and methods of analysis. Food Chem Toxicol. 40: 1327-1333, 2002. Go to original source... Go to PubMed...
  3. Allon N, Chapman S, Egozi I, Rabinovitz I, Kapon J, Weissman BA, Yacov G, Bloch-Shilderman E, Grauer E. Deterioration in brain and heart functions following a single sub-lethal (0.8 LCt50) inhalation exposure of rats to sarin vapor: a putative mechanism of the long term toxicity. Toxicol Appl Pharmacol. 253: 31-37, 2011. Go to original source... Go to PubMed...
  4. Brimblecomb RW, Green DM, Stratton JA, Thompson PB. The protective actions of some anticholinergic drugs in sarin poisoning. Brit J Pharmacol. 39: 822-830, 1970. Go to original source... Go to PubMed...
  5. Damodaran TV, Jones KH, Patel AG, Abou-Donia MB. Sarin (nerve agent GB)-induced differential expression of mRNA coding for the acetylcholinesterase gene in the rat central nervous system. Biochem Pharmacol. 65: 2041-2047, 2003. Go to original source... Go to PubMed...
  6. Kassa J, Cabal J. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Hum Exp Toxicol. 18: 560-565, 1999. Go to original source... Go to PubMed...
  7. Li B, Schopfer LM, Grigoryan H, Thompson CM, Hinrichs SH, Hinrichs SH, Masson P, Lockridge O. Tyrosines of human and mouse transferrin covalently labeled by organophosphorus agents: a new motif for binding to proteins that have no acitve site serine. Toxicol Sci. 107: 144-155, 2009. Go to original source... Go to PubMed...
  8. Lowes DA, Galley HF. Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis. Biochem J. 436: 123-132, 2011. Go to original source... Go to PubMed...
  9. Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta. 380: 50-58, 2007. Go to original source... Go to PubMed...
  10. Marrs TC. Organophosphate poisoning. Pharmacol Therapy. 58: 51-66, 1993. Go to original source... Go to PubMed...
  11. McPhalen CA, Vincent MG, Jansonius JN. X-ray structure refinement and comparison of three forms of mitochondrial aspartate aminotransferase. J Mol Biol. 225: 495-517, 1992. Go to original source... Go to PubMed...
  12. Niven AS, Roop SA. Inhalational exposure to nerve agents. Respir Care Clin N Am. 10: 59-74, 2004. Go to original source... Go to PubMed...
  13. Ostergaard D, Viby-Moogensen J, Hanel HK, Skovgaard LT. Half-life of plasma cholinesterase. Acta Anaesthesiol Scand. 32: 266-269, 1988. Go to original source... Go to PubMed...
  14. Pohanka M. Cholinesterases, a target of pharmacology and toxicology. Biomed Pap Olomouc. 155: 219-223, 2011a. Go to original source... Go to PubMed...
  15. Pohanka M. Alzheimer's disease and related neurodegenerative disorders: implication and counteracting of melatonin. J Appl Biomed. 9: 185-196, 2011b. Go to original source...
  16. Pohanka M, Sobotka J, Jilkova M, Stetina R. Oxidative stress after sulfur mustard intoxication and its reduction by melatonin: efficacy of antioxidant therapy during serious intoxication. Drug Chem Toxicol. 34: 85-91, 2010. Go to original source... Go to PubMed...
  17. Pohanka M, Sobotka J, Svobodova H, Stetina R. Investigation of oxidative stress in blood, brain, kidney, and liver after oxime antidote HI-6 application in a mouse experimental model. Drug Chem Toxicol. 34: 255-260, 2011a. Go to original source... Go to PubMed...
  18. Pohanka M, Novotny L, Pikula J. Metrifonate alters antioxidant levels and caspase activity in cerebral cortex of Wistar rats. Toxicol Mech Meth. 21: 585-590, 2011b. Go to original source... Go to PubMed...
  19. Proctor SP, Heaton KJ, Heeren T, White RF. Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans. Neurotoxicology. 27: 931-939, 2006. Go to original source... Go to PubMed...
  20. Schopfer LM, Grigoryan H, Li B, Nachon F, Masson P, Lockridge O. Mass spectral characterization of organophosphate-labeled, tyrosine-containing peptides: characteristic mass fragments and a new binding motif for organophosphates. J Chromatogr B Analyt Technol Biomed Life Sci. 878: 1297-1311, 2010. Go to original source... Go to PubMed...
  21. Shobha TR, Prakash O. Glycosuria in organophosphate and carbamate poisoning. J Assoc Physicians India. 48: 1197-1199, 2000. Go to PubMed...
  22. Tiruvoipati R, Chiezey B, Lewis D, Ong K, Villanueva E, Haji K, Botha J. Stress hyperglycemia may not be harmful in critically ill patients with sepsis. J Crit Care. 27: 153-158, 2011. Go to original source... Go to PubMed...
  23. Wang Y, Weiss MT, Yin J, Tenn CC, Nelson PD, Mikler JR. Protective effects of N-methyl-D-aspartate receptor antagonism on VX-induced neuronal cell death in cultured rat cortical neurons. Neurotox Res. 13: 163-172, 2008. Go to original source... Go to PubMed...
  24. Yanagisawa N, Morita H, Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci. 249: 76-85, 2006. Go to original source... Go to PubMed...